TwinCapsula Celebrates Five Years of Innovation in Bio-logistics with Space Technology-Based Coolers

TwinCapsula’s Milestone: Celebrating Five Years of Transformative Bio-logistics

On March 8, 2026, TwinCapsula Inc. celebrated its fifth anniversary since its founding by recognizing key achievements in bio-logistics utilizing advanced cooling technologies derived from space research by JAXA. Headquartered in Tsukuba, Ibaraki, and led by CEO Kazuhiro Miyazaki, the company has made significant strides in developing the ultra-high performance insulation cooler known as "BAMBOO SHELLter." This initiative aims to integrate technologies validated by space missions into everyday applications, especially in the medical and pharmaceutical transport sectors.

The journey began in 2021 when TwinCapsula was founded and subsequently certified as a JAXA venture. Armed with an ambition to bring space-tested insulation technology to practical use, a strategic partnership was established with Tiger Corporation, a leader in thermal containers. The partnership enabled the prototype development of BAMBOO SHELLter, targeting enhanced reliability in transporting sensitive medical specimens.

In 2022, TwinCapsula conducted successful cold transport experiments in collaboration with aiwell Co., achieving significant milestones that validated the effectiveness of their prototypes in real-world scenarios. This was followed by the release of a beta version of a sleek single-layer thermal container in 2023, furthering the company’s commitment to innovation in storage solutions. The development expanded into dual-layer options and ongoing collaborations with Coordinate Lab to enhance specimen transport services in 2024.

Fast forward to 2025, TwinCapsula plans to unveil the official versions of BAMBOO SHELLter (both single and dual-layer) alongside a one-stop collection and delivery service for specimens. As part of their international expansion, the startup participated in exhibitions and negotiations with Indian firms, showcasing their commitment to grow beyond Japanese borders.

The Next Chapter: A Future Driven by Bio-logistics

As TwinCapsula enters its second chapter, the focus broadens significantly. The company’s vision is to transform BAMBOO SHELLter into a foundational pillar of a next-generation cold chain in the medical and pharmaceutical industries. This evolution aligns with changes in the medical field, as regenerative medicine and personalized healthcare increasingly depend on reliable transport for bio-products, cells, and specimens.

Challenges such as temperature deviations, transport costs, and quality assurance remain bottlenecks within the industry. TwinCapsula aims to redesign these structural challenges by:
1. Expanding domestic and international implementations and establishing standard models.
2. Enhancing collaboration with logistics networks and forwarding agents to introduce advanced one-stop transportation solutions.
3. Developing extreme low-temperature capabilities for long-duration transport requirements.
4. Integrating temperature traceability through data connectivity.
5. Building a robust international business framework, particularly in Asia.

The ambition is clear; TwinCapsula’s BAMBOO SHELLter should effectively integrate into services of healthcare providers, research institutions, and logistics companies, evolving into an indispensable transport infrastructure.

In conjunction with its fifth-anniversary milestone, the company will also launch pioneering social implementation projects collaborating with forward-looking businesses. This strategic move aims to strengthen the integration of space-derived technologies within domestic services, marking a transition from mere transfer capabilities to trustworthy services.

Internal reflections from JAXA highlight the significant contributions TwinCapsula has made to the bio-medical industry, especially with timely innovations in the face of recent global health challenges. Their advanced insulation technology is recognized as critical in improving quality and reliability in biomedical supply chains.

As the next five years unfold, TwinCapsula is poised to redefine the norms of medical logistics, turning space technology into a practical standard. Stakeholders and partners eagerly anticipate this new chapter, understanding its potential to change the landscape of medical logistics globally.